Enfermedad de Behçet
| Agente | Año | Tipo de estudio | Pacientes (n) | TR (n) | Casos adversos | Recaída | Muertes |
|---|---|---|---|---|---|---|---|
| INFLIXIMAB | 2007 |
A |
28 |
12 |
20 |
16 |
0 |
2004 |
C |
13 |
9 |
10 |
3 |
0 |
|
2005 |
C |
6 |
6 |
0 |
2 |
0 |
|
2005 |
C |
13 |
13 |
12 |
3 |
0 |
|
2007 |
C |
12 |
11 |
5 |
5 |
0 |
|
2007 |
C |
12 |
10 |
7 |
3 |
0 |
|
| Total | 81 |
73 |
34 |
22 |
0 |
||
| % | 83,333333 |
41,9753086 |
|||||
| INFLIXIMAB | 2001 |
D |
1 |
1 |
1 |
0 |
0 |
2001 |
D |
1 |
1 |
0 |
0 |
0 |
|
2001 |
D |
1 |
1 |
0 |
0 |
0 |
|
2001 |
D |
5 |
5 |
0 |
0 |
0 |
|
2001 |
D |
2 |
2 |
1 |
2 |
0 |
|
2001 |
D |
1 |
1 |
0 |
0 |
0 |
|
2002 |
D |
1 |
1 |
0 |
0 |
0 |
|
2002 |
D |
1 |
1 |
0 |
0 |
0 |
|
2002 |
D |
1 |
1 |
0 |
0 |
0 |
|
2002 |
D |
1 |
1 |
0 |
0 |
0 |
|
2003 |
D |
1 |
1 |
0 |
0 |
0 |
|
2003 |
D |
1 |
1 |
0 |
0 |
0 |
|
2003 |
D |
1 |
1 |
0 |
0 |
0 |
|
2004 |
D |
2 |
1 |
2 |
2 |
0 |
|
2004 |
D |
1 |
1 |
0 |
0 |
0 |
|
2004 |
D |
1 |
1 |
1 |
0 |
0 |
|
2004 |
D |
1 |
1 |
0 |
1 |
0 |
|
2004 |
D |
4 |
4 |
0 |
2 |
0 |
|
2005 |
D |
1 |
1 |
0 |
0 |
0 |
|
2005 |
D |
5 |
4 |
0 |
3 |
0 |
|
2005 |
D |
4 |
2 |
1 |
1 |
0 |
|
2005 |
D |
1 |
1 |
0 |
1 |
0 |
|
2005 |
D |
1 |
1 |
0 |
0 |
0 |
|
2006 |
D |
1 |
1 |
0 |
0 |
0 |
|
2006 |
D |
5 |
5 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
0 |
1 |
0 |
0 |
|
2007 |
D |
1 |
0 |
0 |
0 |
1 |
|
2007 |
D |
1 |
1 |
0 |
1 |
0 |
|
| Total | 52 |
46 |
7 |
13 |
1 |
||
| % | 88,461538 |
13,4615385 |
|||||
| ETANERCEPT | 2005 |
A |
20 |
20 |
1 |
1 |
0 |
100% |
5 |
||||||
| ETANERCEPT | 2002 |
D |
1 |
0 |
0 |
0 |
0 |
2002 |
D |
2 |
2 |
0 |
2 |
0 |
|
2005 |
D |
1 |
1 |
0 |
0 |
0 |
|
2005 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
1 |
0 |
|
| % | 6 |
5 |
0 |
3 |
0 |
||
83,333333 |
0 |
||||||
| ADALIMUMAB | 2007 |
D |
6 |
6 |
3 |
1 |
0 |
2007 |
D |
3 |
3 |
0 |
0 |
0 |
|
| Total | 9 |
9 |
3 |
1 |
0 |